🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This retrospective cohort study investigates the effects of SGLT2 inhibitor...
Status
Active Not Recruiting
Location
University Medical Centre Ljubljana
Start Date
2019-01-01
Trial ID
NCT07478575
Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Status
Unknown
Location
Kurume University Hospital
Start Date
2015-08
Trial ID
NCT02528019
Treatments Being Tested
BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Status
Completed
Location
Unit of Endocrinology and Metabolic Diseases
Start Date
2019-11-27
Trial ID
NCT04196231
Treatments Being Tested
The novel sodium-glucose cotransporter-2 (SGLT2) inhibitor, enavogliflozin,...
Status
Recruiting
Location
Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea
Start Date
2024-01-22
Trial ID
NCT06642623
Treatments Being Tested
The pharmacokinetics (PK) and pharmacodynamics (PD) of bisoprolol and sodiu...
Status
Completed
Location
Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, University Hospital Saarland, Saarland University
Start Date
2023-05-01
Trial ID
NCT06453577
Treatments Being Tested
This clinical study aims to improve the diagnosis and treatment of cardiova...
Status
Active Not Recruiting
Location
PI "National Laboratory Astana", Nazarbayev University
Start Date
2024-12-18
Trial ID
NCT07303556
Treatments Being Tested
To rule out the beneficial effect of SGLT2-I to reduce liver fat, and chang...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06668753
Treatments Being Tested
gemigliptin,SGLT-2i DDI study...
Status
Unknown
Location
LG chem
Start Date
2018-04-05
Trial ID
NCT03565458
Treatments Being Tested
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
Patients with type 2 diabetes (T2D) are more prevalent with aging-related c...
Status
Unknown
Location
Yonsei University College of Medicine
Start Date
2023-06-01
Trial ID
NCT05975528
Treatments Being Tested